Most Recent
End of the road for AI inventions, as High Court rejects patent appeal
The High Court will not wade into the global debate over whether artificial intelligence inventions should receive patent protection, letting stand a Full Court judgment that overturned a landmark victory for AI pioneer Dr Stephen Thaler.
The Economist loses challenge to ‘The Beer Economist’ trade mark
Media company The Economist has failed in its opposition to registration of a trade mark for The Beer Economist, with an IP Australia delegate saying the mark was not substantially identical or deceptively similar to the UK publisher's brand.
A2 Milk faces latest attack on ‘A2’ trade marks
Infant formula maker Care A2 Plus has launched an attack on A2 Milk, filing a lawsuit arguing the dairy giant's trade marks should be cancelled because they're too generic and are being used to sell products that don't exclusively contain the a2 protein.
Finish detergent maker says trade mark judgment doesn’t wash
The maker of Finish dishwashing products has appealed a judgment that removed two of its trade marks for non-use and rejected its claim that a competitor's logo was deceptively similar.
IP firm Marquette resolves suit by lawyer allegedly fired for complaints of bullying
Boutique firm Marquette IP has reached a settlement with a former trade mark attorney who claimed she was sacked for making complaints of bullying by a supervisor. 
Kanye West takes beef with Melbourne restaurant to court
Melbourne restaurant College Dropout Burgers has been hit with a lawsuit by Kanye West for allegedly using the controversial rapper's name and likeness without permission.
Super fund sues crypto company for ‘flagrant’ trade mark infringement
Education superannuation fund NGS Super has filed a trade mark lawsuit against Australian blockchain mining company NGS Crypto, claiming it failed to comply with a promise to rebrand and continues to profit at the fund’s expense. 
Sanofi challenges Amgen’s patents for cholesterol-lowering antibodies
French drug giant Sanofi has appealed a decision giving American biopharmaceutical company Amgen the go-ahead for its patents for a cholesterol-lowering antibody that could be used to treat heart disease, diabetes, stroke and Alzheimer’s.
Cheese makers challenge Kraft’s ‘parmesan’ trade mark
A consortium of parmigiano reggiano producers who claim Kraft Foods' 'Kraft parmesan cheese' trade will lead customers to believe the food giant's cheese is made in Italy have taken their fight to the Federal Court.